Table: Phoenixbio - 6-MTH group results

PhoenixBio

12/11/2021 06:30

Nov 12 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2021        Sep 30, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            637 mln             301 mln            1.30      
                                     (-42.2 pct)                    
  Operating     loss 133 mln        loss 288 mln      loss 155 mln  
  Recurring     loss 128 mln        loss 265 mln      loss 156 mln  
  Net           loss 130 mln        loss 267 mln      loss 157 mln  
  EPS          loss 39.59 yen      loss 83.98 yen    loss 47.69 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T